Location History:
- Proteos, SG (2018)
- Singapore, SG (2018 - 2019)
Company Filing History:
2 out of 1,506 
1 out of 93 
1 out of 818 
Years Active: 2018-2019
Title: Innovations by Jean Paul Thiery
Introduction
Jean Paul Thiery is a notable inventor based in Singapore, known for his contributions to the field of medical diagnostics. He holds a total of 3 patents that focus on biomarkers and methods for cancer detection and risk assessment. His work has significant implications for improving patient outcomes in oncology.
Latest Patents
Thiery's latest patents include groundbreaking innovations in cancer biomarkers. One of his patents discloses bladder cancer protein biomarkers that aid in determining whether a patient suffers from or shows recurrence of bladder cancer. This patent outlines methods for detecting early and late-stage bladder cancer using specific biomarkers such as Coronin-IA, Apolipoprotein A-IV, Semenogelin-2, Gamma-synuclein, and DJ-1. Another significant patent involves a method for determining the risk of metastatic relapse in patients diagnosed with colorectal cancer. This method includes detecting levels of indicators of metastatic potential in biological samples and comparing them with control levels to identify patients at risk.
Career Highlights
Throughout his career, Jean Paul Thiery has worked with esteemed institutions such as the Agency for Science, Technology and Research and Kuwait University. His experience in these organizations has contributed to his expertise in cancer research and diagnostics.
Collaborations
Thiery has collaborated with notable colleagues, including Prashant Kumar and Jayantha Gunaratne, enhancing the impact of his research through teamwork and shared knowledge.
Conclusion
Jean Paul Thiery's innovative work in cancer biomarkers and detection methods showcases his commitment to advancing medical science. His patents reflect a dedication to improving diagnostic techniques and patient care in oncology.